All News

This patient had a history of pelvic pain and five weeks amenorrhea with no h/o spotting. What is your diagnosis?

A study found substantially improved survival of offspring for women who received prenatal multiple micronutrient supplementation and early invitation to food supplementation.

A review of women's health studies reveals that the hormonal fluctuations women experience throughout their lives can change conditions in the mouth, allowing for health changes.

A new study indicates that some female cancer survivors develop breast cancer as a consequence of radiation exposure.

Social media is opening up what you can do with your practice.

Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.

A reversible topical male contraceptive may be close r to reality, based of the results of a randomized trial.

Bleeding disorders can create problems with reproductions.

A review of several lawsuits covering acid solution errors, prolapse, fetal weight, breast cancer diagnosis, and complications following fibroid embolization.

A new assessment of what late and variable decelerations mean.

A population-based study indicates that extremes in birthweight lead to an increased risk of stillbirth.

Hyperemesis causes a variety of problems to mothers during pregnancy and a tiered approach can prove beneficial.

Bleeding disorders can create problems with reproductions.

The United States Food and Drug Administration (FDA), under its priority review program, recently approved PerjetaTM (pertuzumab), a HER2/neu receptor antagonist indicated in combination with HerceptinR (trastuzumab), another HER2 therapy, and docetaxel for treatment of HER2-positive metastatic breast cancer (BCa) in women who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

Analysis by the United States Food and Drug Administration (FDA) of compounded 17α-hydroxyprogesterone caproate (17P) shows the samples meet the potency and total purity standards for Makena, the branded version of the drug. Testing was done on 16 samples of bulk 17P active pharmaceutical ingredients (API) in response to questions from K-V Pharmaceuticals, Makena’s sponsor, about potency and purity of the compounded product.

Although risks increase after an EP, a history of EP alone does not warrant closer-than-usual monitoring during a future pregnancy.

Scientists are testing a procedure that allows women with a genetic disorder conceive without passing the disease on to their children, and it involves using DNA from a "third parent." Is it ethical?

What is your diagnosis in this 40 year-old female patient with severe suprapubic pain exacerbated during menses? Ovaries were normal.

Estrogen-deficient women who have had a hysterectomy with or without ovarian preservation are more likely to have arterial stiffness than estrogen-deficient women who have not had a hysterectomy, according to results of a new study conducted at the University of Colorado School of Medicine in Denver.

A national survey of ob/gyn residents indicates that most do not grasp important statistical information. And practicing physicians don't perform much better.

Nearly three-quarters of ob/gyn residents were unable to identify the positive predictive value of a screening mammogram on a multiple choice test, yet 80% believed they had adequate training in statistical literacy.

The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.

The U.S. Preventive Services Task Force has issued draft recommendations for postmenopausal hormone therapy for the primary prevention of chronic conditions, such as heart disease, stroke, dementia, hip fracture, and breast cancer.

This is the case of a pregnancy at 12 weeks gestational age. The patient underwent routine prenatal transabdominal and transvaginal ultrasound imaging.

Omission of the bladder flap in cesarean deliveries does not increase intraoperative or postoperative complications, according to results of a new randomized controlled trial.

In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research.

In a highly critical re-analysis of the Women’s Health Initiative (WHI) study of 2002, the results of which prompted safety fears about hormone replacement therapy (HRT) significantly increasing the risk of breast cancer, it was concluded that the weight of evidence supports benefits over risks for use of HRT in women with severe symptoms of menopause or other conditions.

A 39 year-old woman presented with urinary frequency and pelvic pressure. On pelvic examination, a large pelvic mass was felt adjacent to the uterus, deep in the pelvis. MRI showed a 12 cm subserosal fibroid adjacent to the right side of the uterus.